Regency Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2K | Hold |
29,500
| – | – | 0.02% | 58 |
|
|
2025
Q1 | $46.9K | Hold |
29,500
| – | – | 0.03% | 43 |
|
|
2024
Q4 | $89.4K | Hold |
29,500
| – | – | 0.05% | 49 |
|
|
2024
Q3 | $109K | Hold |
29,500
| – | – | 0.06% | 46 |
|
|
2024
Q2 | $121K | Hold |
29,500
| – | – | 0.08% | 47 |
|
|
2024
Q1 | $465K | Sell |
29,500
-300
| -1% | -$4.73K | 0.3% | 41 |
|
|
2023
Q4 | $451K | Buy |
29,800
+14,800
| +99% | +$224K | 0.3% | 42 |
|
|
2023
Q3 | $301K | Buy |
+15,000
| New | +$301K | 0.26% | 39 |
|